SCHEMBL10000759

SCHEMBL10000759

CC1=CC(=O)C(CO)=C(CO)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MAPT P10636 4/20 0.41
MEN1 O00255 3/20 0.41
MAPK1 P28482 3/20 0.41
BLM P54132 3/20 0.41
KMT2A Q03164 3/20 0.41
USP2 O75604 2/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 2/20 0.41
RECQL P46063 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
THRB P10828 1/20 0.41
RAB9A P51151 1/20 0.41
TXNRD1 Q16881 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
IDO1 P14902 4/20 0.39
TP53 P04637 2/20 0.39
CYP1A2 P05177 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5712767 0.74 PIM1 (0.31)
SCHEMBL20817157 0.73 MEN1 (0.32) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL5536622 0.70 XIAP (0.68) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL12744504 0.69 ALOX15 (0.32) MAPTMAPK1CYP3A4CDC25BLMNA
SCHEMBL11790353 0.68 XIAP (0.41) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL5712735 0.68 KDM4E (0.31) ALDH1A1MAPTMEN1BLMKMT2A
SCHEMBL3624714 0.68 ALDH1A1 (0.50) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL9875880 0.67 STAT3 (0.37) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL3968141 0.65 STAT3 (0.59) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL8138381 0.65 MEN1 (0.34) ALDH1A1MAPTMEN1MAPK1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207229-B1 Preparation of hydroquinone amide compounds with antioxidant properties CATALYS SAS (FR) 2012-06-26 US disclosed
US-8207229-B1 Preparation of hydroquinone amide compounds with antioxidant properties CATALYS SAS (FR) 2012-06-26 US disclosed
US-8003824-B2 Preparation of hydroquinone amide compounds with antioxidant properties CATALYS SAS (FR) 2011-08-23 US disclosed
US-8003824-B2 Preparation of hydroquinone amide compounds with antioxidant properties CATALYS SAS (FR) 2011-08-23 US disclosed
EP-2257523-B1 PREPARATION OF HYDROQUINONE AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES CATALYS SAS (FR) 2011-08-10 EP disclosed
US-20110021820-A1 Preparation of Hydroquinone Amide Compounds with Antioxidant Properties CATALYS SAS (FR) 2011-01-27 US disclosed
US-20110021820-A1 Preparation of Hydroquinone Amide Compounds with Antioxidant Properties CATALYS SAS (FR) 2011-01-27 US disclosed
WO-2009115707-A2 PREPARATION OF HYDROQUINONE AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES. CATALYS SAS (FR) 2009-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021820-A1 Preparation of Hydroquinone Amide Compounds with Antioxidant Properties NQO1, TYR, AHR ALDH1A1 27/4885MAPT 4244/4885MEN1 4515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.